Medtronic

MEDTRONIC NEWSROOM (47 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2025 2024 2023 2018 2017 2016 2015 2014

Study Showcases Economic Value of Earlier Patient Access to Medtronic Cardiac Resynchronization Therapy Devices

PRESS RELEASE -- 28, February 2017

DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced an economic analysis of five-year data showing that patients with mild heart failure who get cardiac resynchronization therapy (CRT) devices early in their treatment live longer and that implanting these devices … Read the full press release →

Medtronic to present at the 37th Annual Cowen and Company Healthcare Conference on March 7, 2017

PRESS RELEASE -- 28, February 2017

DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc  (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual Cowen and Company Healthcare Conference on Tuesday, March 7, 2017, in Boston, Mass. Geoff Martha, executive vice president … Read the full press release →

Medtronic receives CE (Conformité Européenne) Mark for its suite of quadripolar cardiac resynchronization therapy pacemakers

PRESS RELEASE -- 28, February 2017

Suite of Smart Heart Failure Devices Offers More-Effective Pacing, Expanded MRI Access DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for a suite of quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps) that … Read the full press release →

Medtronic presents results supporting the IN.PACT® Admiral® drug-coated balloon in patients with peripheral arterial disease

PRESS RELEASE -- 25, January 2017

First Presentation of Results from Regional Cohorts of IN.PACT Global Study Reinforce Strong, Consistent and Safe Outcomes for PAD Patients  DUBLIN and LEIPZIG, 25-Jan-2017 — /EuropaWire/ — Medtronic today presented new data at the Leipzig Interventional Course (LINC) 2017 conference supporting … Read the full press release →

Medtronic expands directional atherectomy portfolio in Europe with new 6F HawkOne

PRESS RELEASE -- 25, January 2017

Expands Treatment Options for Patients in Europe with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced CE (Conformité Européene) Mark approval for the HawkOne(TM) directional atherectomy system in a … Read the full press release →

Medtronic announces first procedure using Visualase(TM) MRI-Guided Laser Ablation System for treatment of common form of epilepsy

PRESS RELEASE -- 25, January 2017

DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) announced today that the first procedure using the Visualase(TM) MRI-Guided Laser Ablation System has been performed in the pivotal SLATE (Stereotactic Laser Ablation for Temporal Lobe Epilepsy) clinical trial at Mayo Clinic … Read the full press release →

Medtronic: launch of the largest sized transcatheter aortic valve replacement (TAVR) system available in the U.S.

PRESS RELEASE -- 27, October 2016

Launch of 34 mm Self-Expanding Evolut R Device Expands TAVR Treatment to Patients Who Could Not be Treated Previously DUBLIN, 27-Oct-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of … Read the full press release →

Medtronic: U.S. FDA approval for HawkOne Directional Atherectomy System for patients with peripheral artery disease (PAD)

PRESS RELEASE -- 27, October 2016

New Technology Expands Treatment Options for Patients with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 27-Oct-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne(TM) Directional Atherectomy … Read the full press release →

Medtronic announced U.S. commercial availability of its MiniMed Connect mobile accessory for Android

PRESS RELEASE -- 27, October 2016

MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns DUBLIN, 27-Oct-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of … Read the full press release →

Medtronic’s Hybrid Closed Loop system pivotal trial results published in the Journal of the American Medical Association

PRESS RELEASE -- 16, September 2016

DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of its Hybrid Closed Loop system pivotal trial results in the Journal of the American Medical Association (JAMA). The data presented the safety of the system … Read the full press release →

Medtronic announces the appointment of Mark Ploof as SVP, Global Operations and Business Services

PRESS RELEASE -- 16, September 2016

DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic (NYSE: MDT) today announced the appointment of Mark Ploof as Senior Vice President, Global Operations and Business Services effective October 31, 2016.  He will serve on the company’s Executive Committee and be responsible for leading … Read the full press release →

Medtronic received Ministry of Health, Labor and Welfare approval for its Reveal LINQ Insertable Cardiac Monitor System in Japan

PRESS RELEASE -- 16, September 2016

Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke  DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of the Reveal LINQ Insertable Cardiac … Read the full press release →

Medtronic’s IN.PACT Admiral drug-coated balloon treatment for in-stent restenosis receives FDA approval

PRESS RELEASE -- 16, September 2016

IN.PACT Admiral DCB Indication Expansion to Treat Patients with ISR DUBLIN, 16-Sep-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) as a treatment for in-stent … Read the full press release →

Medtronic plc SureTune2(TM) software receives CE Mark

PRESS RELEASE -- 10, August 2016

New Visual-Based Platform Helps Physicians Make Informed Programming Decisions by Providing an Intuitive Visualization of Patient-Specific Images and Data DUBLIN, 10-Aug-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for SureTune2(TM) software, which … Read the full press release →

Diabetes Management: Medtronic announced new product developments and technology partnerships at the American Diabetes Association (ADA) 76th Scientific Sessions

PRESS RELEASE -- 10, June 2016

CareLink® Portfolio Updates, IBM Watson Partnership Progress and New Strategic Alliances Delivering Intelligent Data and Actionable Information at ADA 2016 DUBLIN and NEW ORLEANS, 10-Jun-2016 — /EuropaWire/ — Delivering on its vision to transform care for the millions currently living with … Read the full press release →

Medtronic presents FIRE AND ICE clinical trial findings at a late-breaking session at CARDIOSTIM-EHRA EUROPACE 2016

PRESS RELEASE -- 10, June 2016

Secondary Analyses Presented at Cardiostim 2016 Highlight Positive, Real-World Patient Outcomes DUBLIN AND NICE, FRANCE, 10-Jun-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced findings from the secondary analyses of theFIRE AND ICE clinical trial that demonstrate significantly fewer repeat … Read the full press release →

Medtronic presents results of new approach to implantable cardioverter defibrillator (ICD) therapy at CARDIOSTIM / EHRA EUROPACE 2016

PRESS RELEASE -- 9, June 2016

Places ICD Leads Under Rib Cage, Outside Heart and Veins DUBLIN and NICE, FRANCE, 09-Jun-2016 — /EuropaWire/ — Medtronic plc (NSYE: MDT) today announced results from several feasibility studies evaluating a new approach to implantable cardioverter defibrillator (ICD) therapy at CARDIOSTIM … Read the full press release →

Medtronic / University of Texas: First patient enrolled in a clinical study for the minimally invasive repair of descending thoracic aortic aneurysms (TAA)

PRESS RELEASE -- 9, June 2016

Unique Next-Generation Device Evaluated in International Clinical Trial; First Procedure Performed at the University of Texas Health Science Center at Houston DUBLIN and HOUSTON, 09-Jun-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) and the University of Texas Health Science Center at … Read the full press release →

Lung cancer: Medtronic announced European enrollment in the NAVIGATE clinical trial

PRESS RELEASE -- 14, March 2016

NAVIGATE Study Assesses Impact of Minimally Invasive Technology to Aid in Early Diagnosis and Treatment of Lung Cancer DUBLIN, 14-Mar-2016 — /EuropaWire/ — Committed to technologies that assist in the goal of reducing lung cancer morbidity worldwide, Medtronic (NYSE: MDT) today … Read the full press release →

Medtronic presented results of iPro2 Professional CGM at 9th International Conference on Advanced Technologies & Treatments for Diabetes

PRESS RELEASE -- 8, February 2016

iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy MILAN, 08-Feb-2016 — /EuropaWire/ — A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (NYSE:MDT), the global leader in medical technology, … Read the full press release →